Last update 21 Nov 2024
Insulin Degludec biosimilar (Huisheng Biological)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Insulin degludec Biosimilar (Jilin Huisheng Biological Pharmaceutical Co., Ltd.), 德谷胰岛素生物类似药（Jilin Huisheng Biological Pharmaceutical Co., Ltd.）, 惠优达 + [1] |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (05 Aug 2024), |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 4857
The sequence is quoted from: *****
Sequence Code 91440
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Insulin Degludec biosimilar (Huisheng Biological)德谷胰岛素注射液治疗2型糖尿病的有效性和安全性的多中心、随机、开放、平行组、阳性对照的III期研究
[Translation] A multicenter, randomized, open, parallel-group, positive-controlled phase III study on the efficacy and safety of degludec insulin injection in the treatment of type 2 diabetes
评价德谷胰岛素注射液与诺和达在中国健康受试者中的PK/PD及安全性随机、开放、单剂量、两周期、交叉临床研究
[Translation] A randomized, open-label, single-dose, two-period, crossover clinical study to evaluate the PK/PD and safety of degludec insulin injection and Tresiba in healthy Chinese subjects
100 Clinical Results associated with Insulin Degludec biosimilar (Huisheng Biological)
Login to view more data
100 Translational Medicine associated with Insulin Degludec biosimilar (Huisheng Biological)
Login to view more data
100 Patents (Medical) associated with Insulin Degludec biosimilar (Huisheng Biological)
Login to view more data
100 Deals associated with Insulin Degludec biosimilar (Huisheng Biological)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | CN | 05 Aug 2024 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | CN | 28 Nov 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free